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Autophagy regulates the degradation of both cellular components and invading intracellular pathogens. In
this issue ofCell Host &Microbe,Maurer et al. (2015) reveal that cellular autophagy decreases host sensitivity
to Staphylococcus aureus a-toxin via reduced expression of the toxin receptor ADAM10, thus rendering the
host tolerant to disease.Autophagy is a conserved host cellular
process that targets intracellular contents
for degradation at a basal level under
nutrient-rich conditions and is highly upre-
gulated during times of cellular starvation.
In addition to its housekeeping function,
autophagy is awell-appreciated innate im-
munemechanismfor the targeteddestruc-
tion of intracellular bacteria. The formation
of a double-membrane autophagosomal
compartment encapsulates the invading
organism to restrict bacterial growth and
permit delivery to the lysosome for degra-
dation. Bacteria have evolved an array
of mechanisms to alter the autophagic
process, including inhibition of signaling,
blockade of autophagosomal assembly,
and production of virulence factors that
conceal the bacteria from recognition and
prevent lysosomal fusion (Huang and Bru-
mell, 2014). Staphylococcus aureus is a
formidable human pathogen owing to its
ability to cause invasive pneumonia andsepsis, resulting in significant morbidity
and mortality. S. aureus a-toxin is a highly
conserved exotoxin that plays a vital role
in the progression of both intrapulmonary
and intravascular infection, contributing
to pathogen-associatedmortality (Bubeck
Wardenburg et al., 2007; Powers et al.,
2012). Limited in vitro studieshavedemon-
strated that a-toxin upregulates auto-
phagy, allowing for bacterial replication
in the autophagosome and escape into
the cytosol (Mestre et al., 2010; Schnaith
et al., 2007); however, the precise contri-
bution of host autophagy to progression
of staphylococcal infection in vivo had re-
mained elusive.
In the current issue of Cell Host &
Microbe, Maurer et al. utilize autophagy-
deficient ATG16L1 hypomorphic mice to
address the role of autophagy during
invasive S. aureus disease. The authors
uncover that autophagy mutants display
increased mortality during both intrave-nous and intrapulmonary S. aureus infec-
tion, a stark contrast to the group’s previ-
ous observation of protection following
Citrobacter rodentium infection (March-
iando et al., 2013). Surprisingly, the
increased death and organ damage de-
tected in S. aureus-infected mice does
not correlate with increased bacterial
burden, suggesting that the mechanism
of increased susceptibility is independent
of the most widely proposed innate im-
mune function of autophagy-mediated
bacterial clearance. Given the well-char-
acterized contribution of a-toxin to the
pathogenesis of pneumonia and sepsis,
the authors tested disease progression
in autophagy hypomorphs utilizing strains
of S. aureus lacking the toxin. These ex-
periments not only reveal that the hyper-
sensitivity of autophagy-deficient mice is
lost during infection with the isogenic
mutant, but autophagy-deficient mice
are in fact more tolerant to toxin-deficiente 17, April 8, 2015 ª2015 Elsevier Inc. 419
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phagy therefore appears to serve a vital
purpose in innate immunity by allowing
the host to withstand cellular exposure
to a-toxin.
The enhanced susceptibility to sepsis
and the vascular injury observed during
pulmonary infection led the authors to
hypothesize that defective endothelial
autophagy may be relevant to invasive
disease. Consistent with this hypothesis,
endothelial-specific ATG16L1 mice ex-
hibited increased susceptibility to staphy-
lococcal pneumonia and sepsis. Endo-
thelial cells isolated from these mice
exhibit increased cell death in response
to intoxication, highlighting an integral
role of toxin-mediated endothelial injury
in multiple invasive diseases. a-toxin
has been shown to intoxicate myeloid
lineage cells, facilitating the pathogenesis
of pneumonia (Becker et al., 2014).
ATG16L1-specific deletion on myeloid
lineage cells did not enhance infection,
however, suggesting that autophagy-
mediated toxin sensitivity exhibits cellular
specificity in vivo. a-toxin targets suscep-
tible host cells through an interaction
with its cellular receptor A Disintegrin
and Metalloprotease 10 (ADAM10) (Wilke
and Bubeck Wardenburg, 2010). Both
ATG16L1-deficient endothelial cells and
endothelial cells treated with an auto-
phagy inhibitor exhibit a marked increase
in surface ADAM10 expression, providing
an explanation for increased toxin sensi-
tivity. Previous studies corroborate the
findings that increased autophagy corre-
lates with decreased ADAM10 expres-
sion, as the autophagy inducer rapamycin
decreases the production of the neu-
roprotective ADAM10-derived cleavage
product, APP-a (Zhang et al., 2010). The
identification of ADAM10 as the a-toxin
receptor has facilitated an understanding
of pathogenic events downstream of
the of toxin-receptor interaction in vivo.
a-toxin targets both endothelial cells and
epithelial cells, upregulating the enzy-
matic activity of ADAM10 and culminating
in disruption of the tissue barrier in vitro
and in vivo (Inoshima et al., 2011; Powers
et al., 2012). Intoxication of these cell
lineages thereby contributes to mortality420 Cell Host & Microbe 17, April 8, 2015 ª2associated with sepsis and pneumonia
(Inoshima et al., 2011; Powers et al.,
2012). The authors’ finding that increased
ADAM10 expression in autophagy-defi-
cient mice exacerbates S. aureus in-
fection confirms the vital interaction of
the toxin-ADAM10 complex in bacterial
pathogenesis. Moreover, this observation
raises the interesting possibility that auto-
phagy may more broadly govern sus-
ceptibility to bacterial virulence factors
whose action depends on specific host
effector proteins or cognate receptor-
based interactions.
The novel studies by Maurer et al.
enhance our understanding of the con-
tribution of autophagy to host immu-
nity. While autophagy serves a vital
role in combating intracellular patho-
gens through bacterial destruction, these
findings provide a mechanistic link
between toxin-induced cellular injury
and host tolerance. As S. aureus triggers
fulminant disease while being a predomi-
nately extracellular organism, tolerance
as an immunodefense capable of ‘‘mini-
mizing damage caused by the infection
without affecting pathogen burden’’ is
well exemplified by this specific host-
pathogen interaction. Ongoing analysis
of autophagy in specific cell populations
following S. aureus infection is therefore
anticipated to shed further mechanistic
insights on the active contribution of this
process to host tolerance. While invasive
diseases such as sepsis and pneumonia
are a keen focus of therapeutic interven-
tions, owing to their associated morbidity
and mortality, on a population level, these
infections are only a sliver of the interac-
tion of S. aureus with its human host. By
and large, these often-lethal infections
are not ‘‘tolerated’’ by individual patients,
save for the advent of medical interven-
tions including antimicrobial and support-
ive therapies. This raises two intriguing
areas for further inquiry within the field:
first, does autophagy shape the ability of
S. aureus to live as a human commensal,
given the highly conserved nature of
a-toxin? Second, as there is considerable
variability of clinical outcome in patients
treated for invasive S. aureus disease, is
it possible to envision that objective015 Elsevier Inc.measures of host autophagic function
or pathogen tolerance may inform
outcomes and clinical management
through predictive modeling? As such, a
host-specific autophagy ‘‘rheostat’’ may
govern the early response to invasive dis-
ease and establish an outcome trajectory
for the host. The observation by Maurer
and colleagues that epirubicin-enhanced
autophagy protects mice from disease
suggests that deliberate, timely reprog-
ramming of the rheostat set-point in life-
threatening S. aureus infection may be a
novel and viable therapeutic strategy.
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